Behr W, Barnert J, Wienbeck M
Institut für Laboratoriumsmedizin, Zentralklinikum Augsburg.
Dtsch Med Wochenschr. 1988 Nov 4;113(44):1718-22. doi: 10.1055/s-2008-1067878.
In two patients admitted to hospital-one with signs of cerebral infarction, the other with headaches, vertigo and paraesthesias-the TPHA test was "reactive", while the 19S(IgM)-FTA-ABS test was not. There was no cerebrospinal fluid (CSF) pleocytosis. Further CSF analyses and serological tests for syphilis (including CSF protein profile, demonstration of oligoclonal IgG, quantitative determination of Treponema-specific antibodies in serum and CSF) confirmed the diagnosis of neurosyphilis requiring treatment. In both patients the biologically false-negative 19S(IgM)-FTA-ABS test at first became transiently reactive after treatment. This unusual finding was probably due to antigen, liberated by treatment, again stimulating previously blocked IgM antibody synthesis. The listed additional tests should be performed in all patients with a reactive TPHA test and neurological or psychiatric signs and symptoms.
收治入院的两名患者中,一名有脑梗死体征,另一名有头痛、眩晕和感觉异常,梅毒螺旋体血凝试验(TPHA)结果呈“阳性”,而19S(IgM)荧光密螺旋体抗体吸收试验(FTA-ABS)结果为阴性。脑脊液(CSF)中无细胞增多现象。进一步的脑脊液分析和梅毒血清学检测(包括脑脊液蛋白谱、寡克隆IgG检测、血清和脑脊液中梅毒螺旋体特异性抗体的定量测定)确诊为需要治疗的神经梅毒。两名患者经治疗后,起初呈生物学假阴性的19S(IgM)-FTA-ABS试验均暂时转为阳性。这一不寻常的发现可能是由于治疗释放的抗原再次刺激了先前被阻断的IgM抗体合成。对于所有TPHA试验呈阳性且有神经或精神症状体征的患者,均应进行上述额外检测。